Development and course of heart failure after a myocardial infarction in younger and older people
暂无分享,去创建一个
Azam Torabi | A. Rigby | J. Cleland | A. Torabi | Nasser Sherwi | John GF Cleland | Alan S Rigby | N. Sherwi
[1] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[2] F. Harrell,et al. Regression modelling strategies for improved prognostic prediction. , 1984, Statistics in medicine.
[3] Eric Boersma,et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour , 1996, The Lancet.
[4] J. Tijssen,et al. Short- and long-term recovery of left ventricular function predicted at the time of primary percutaneous coronary intervention in anterior myocardial infarction. , 2004, Journal of the American College of Cardiology.
[5] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.
[6] J. Boura,et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .
[7] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.
[8] J. Daubert,et al. Cardiac resynchronization therapy: are modern myths preventing appropriate use? , 2009, Journal of the American College of Cardiology.
[10] J. Cleland,et al. Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: A report from the SPORTIF III and V trials , 2007, European journal of heart failure.
[11] W. Rogers,et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. , 2000, The New England journal of medicine.
[12] L. Wilhelmsen,et al. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment. , 2001, European heart journal.
[13] G. Parodi,et al. Prevalence, predictors, time course, and long-term clinical implications of left ventricular functional recovery after mechanical reperfusion for acute myocardial infarction. , 2007, The American journal of cardiology.
[14] A. D. Cunningham,et al. Post-traumatic focal true left ventricular aneurysm , 2004, Heart.
[15] F H Sheehan,et al. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. , 1987, Circulation.
[16] David A. Schoenfeld,et al. Partial residuals for the proportional hazards regression model , 1982 .
[17] R. Burrow,et al. Heart , 2013, Feline Soft Tissue and General Surgery.
[18] A. Parkhomenko,et al. Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction ≤30% , 2006, European journal of heart failure.
[19] M. Pfeffer,et al. VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context , 2003, European journal of heart failure.
[20] M L Simoons,et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). , 2002, European heart journal.
[21] Jeroen J. Bax,et al. Impact of time to reperfusion after acute myocardial infarction on myocardial damage assessed by left ventricular longitudinal strain. , 2009, The American journal of cardiology.
[22] M. Gotsman,et al. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. , 1985, The New England journal of medicine.
[23] Robert M Califf,et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.
[24] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[25] P. Quandalle,et al. The effect of ageing on cardiac remodelling and hospitalization for heart failure after an inaugural anterior myocardial infarction. , 2008, European heart journal.
[26] A. Rigby,et al. The timing of development and subsequent clinical course of heart failure after a myocardial infarction. , 2008, European heart journal.
[27] H. Dargie,et al. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.
[28] M. Morice,et al. Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry. , 2006, European heart journal.
[29] G. Montalescot,et al. High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study. , 2012, European heart journal.
[30] J. Herlitz,et al. Survival, mode of death, reinfarction and use of medication during a period of 5 years after acute myocardial infarction in different age groups. , 1996, Cardiology.
[31] Samuel O. M. Manda,et al. Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database , 2008, Heart.
[32] Marc P. Bonaca,et al. Vorapaxar in the secondary prevention of atherothrombotic events. , 2012, The New England journal of medicine.
[33] L. Morrison,et al. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. , 2000, JAMA.
[34] P. Herbison,et al. Clinical outcome of older patients with acute coronary syndrome over the last three decades. , 2006, Age and ageing.
[35] Á. Avezum,et al. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). , 2005, American heart journal.
[36] L. Køber,et al. Influence of age on the prognostic importance of left ventricular dysfunction and congestive heart failure on long-term survival after acute myocardial infarction. TRACE Study Group. , 1996, American Journal of Cardiology.